Five financial details:
1. For the fourth quarter, the company expects revenue to range between $15.4 million and $15.6 million, representing a 12 percent to 13 percent increase year over year.
2. Si-Bone’s U.S. revenue for the fourth quarter is anticipate being between $14.3 million and $14.5 million, reflecting a 15 percent to 16 percent increase year over year.
3. The company’s international revenue is expected to be $1.1 million.
4. Si-Bone’s full-year revenue is predicted to range between $55.2 million and $55.4 million, reflecting a 15 percent increase year over year.
5. The company will release its complete financial report and 2019 guidance during the fourth quarter 2018 earnings call in March.
More articles on devices and implants:
SpineSource acquires assets to 2 spinal implant systems: 4 key notes
BioPoly receives European patient for partial resurfacing implant: 3 notes
Shift to outpatient setting drives global orthopedic implants market — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.